Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized studyChristina Fotopoulou, Hani Gabra, Paul N. Mainwaring et al.|Annals of Oncology|2013Cited by 38
A mixed methods approach to developing and evaluating oncology trainee education around minimization of adverse events and improved patient quality and safetyAnna Janssen, Paul R. Harnett|BMC Medical Education|2016Cited by 11